KSH01-TCRT Solid Tumors

Clinical trial NCT05539833 · RECRUITING

Trial details

NCT number: NCT05539833
Sponsor: TCRx Therapeutics Co.Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

TCR-T Cells Refractory Solid Tumors Relapsed Solid Tumors

Start date: 2022-08-19
Primary completion: 2025-07-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.